🔎 Trials Near Me

Akèy › Ekzema › Florid

Etid klinik pou Ekzema nan Florid

9 etid pou Ekzema ap chèche patisipan nan sit nan Florid.

Vil nan Florid

Tèks ofisyèl etid la (Anglè)

Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

  • Clinical Site 110, Miami
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Sep 29, 2026 · NCT07453602

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

  • Novartis Investigative Site, Miami
  • Novartis Investigative Site, St. Petersburg
Ap rekriteFaz 2
Laj 18 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT06947993

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

  • Solutions Through Advanced Research, Jacksonville
Ap rekriteFaz 3
Laj 6 a 11 · Tout sèks · Mizajou Sep 25, 2026 · NCT06807268

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

  • Gsi Clinical Research, Margate
Ap rekriteFaz 2
Laj 18 a 64 · Tout sèks · Mizajou Sep 25, 2026 · NCT07216027

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

  • Solutions Through Advanced Research, Jacksonville
Ap rekriteFaz 3
Laj 2 a 11 · Tout sèks · Mizajou Sep 25, 2026 · NCT06807281

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

  • AllerVie Clinical Research, Panama City
  • GCP Research , Global Clinical Professionals, St. Petersburg
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07765888

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

  • ABMED Clinical Research Corp., Cape Coral
  • Skin Care Research, Hollywood
  • Quality Care Clinical Research, Miami
  • ak 4 plis
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Aug 28, 2026 · NCT07599813

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

  • Inmagene Site 19, Ocala
  • Inmagene Site 4, Tampa
Ap rekriteFaz 2
Laj 18 a 74 · Tout sèks · Mizajou Aug 12, 2026 · NCT07037901

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

  • Revival Research, Doral
  • Floridian Research Institute Llc, Miami
  • Global Health Research Center, Inc., Miami Lakes
  • ak 4 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 4, 2026 · NCT05995964

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.